PROC c.574_576del polymorphism: A common genetic risk factor for venous thrombosis in the Chinese population

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 10, 2012, Pages 2019-2026

  Tang, L ^a,b,c   Lu, X ^a,b,c   Yu, J M ^a,b,c   Wang, Q Y ^a,b,c   Yang, R ^a,b,c   Guo, T ^a,b,c   Mei, H ^a,b,c   Hu, Y ^a,b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Hubei Clinical and Research Center of Thrombosis and Hemostasis   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Genetic risk factor; Polymorphism; Protein C; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; FIBRINOLYTIC FACTOR; PROTEIN C; PROTEIN S;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HOSPITALIZATION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARTIAL THROMBOPLASTIN TIME; PERINATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VEIN THROMBOSIS;

ADULT; AGED; ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; CERCOPITHECUS AETHIOPS; CHI-SQUARE DISTRIBUTION; CHINA; COS CELLS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN C; PROTEIN C DEFICIENCY; RISK ASSESSMENT; RISK FACTORS; TRANSFECTION; VENOUS THROMBOSIS;

EID: 84866866457     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04862.x     Document Type: Article

References (49)

1. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-8.
2. Roberts LN, Patel RK, Arya R. Venous thromboembolism and ethnicity. Br J Haematol 2009; 146: 369-83.
3. Bounameaux H, Rosendaal FR. Venous thromboembolism: why does ethnicity matter? Circulation 2011; 123: 2189-91.
4. Zakai NA, McClure LA. Racial differences in venous thromboembolism. J Thromb Haemost 2011; 9: 1877-82.
5. Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet 2005; 365: 1163-74.
6. Ghanima W, Kleven IW, Enden T, Rosales A, Wik HS, Pederstad L, Holme PA, Sandset PM. Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis. J Thromb Haemost 2011; 9: 1261-3.
7. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107: I9-16.
8. Rosendaal FR, Reitsma PH. Genetics of venous thrombosis. J Thromb Haemost 2009; 7(Suppl. 1): 301-4.
9. Austin H, De Staercke C, Lally C, Bezemer ID, Rosendaal FR, Hooper WC. New gene variants associated with venous thrombosis: a replication study in white and black Americans. J Thromb Haemost 2011; 9: 489-95.
10. Morange PE, Tregouet DA. Lessons from genome-wide association studies in venous thrombosis. J Thromb Haemost 2011; 9(Suppl. 1): 258-64.
11. Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, Coll I, Felices R, Stone W, Fontcuberta J, Blangero J. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic analysis of idiopathic thrombophilia. Am J Hum Genet 2000; 67: 1452-9.
12. Larsen TB, Sorensen HT, Skytthe A, Johnsen SP, Vaupel JW, Christensen K. Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins. Epidemiology 2003; 14: 328-32.
13. Yang Y, Liang L, Zhai Z, He H, Xie W, Peng X, Wang C. Pulmonary embolism incidence and fatality trends in Chinese hospitals from 1997 to 2008: a multicenter registration study. PLoS One 2011; 6: e26861.
14. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
15. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
16. Corral J, Hernandez-Espinosa D, Soria JM, Gonzalez-Conejero R, Ordonez A, Gonzalez-Porras JR, Perez-Ceballos E, Lecumberri R, Sanchez I, Roldan V, Mateo J, Minano A, Gonzalez M, Alberca I, Fontcuberta J, Vicente V. Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis. Blood 2007; 109: 4258-63.
17. Shen MC, Lin JS, Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb Res 1997; 87: 377-85.
18. Liu HW, Kwong YL, Bourke C, Lam CK, Lie AK, Wei D, Chan LC. High incidence of thrombophilia detected in Chinese patients with venous thrombosis. Thromb Haemost 1994; 71: 416-19.
19. Tsuda H, Hattori S, Tanabe S, Iida H, Nakahara M, Nishioka S, Fujise M, Kinoshita S, Okubo K, Hamasaki N. Screening for aetiology of thrombophilia: a high prevalence of protein S abnormality. Ann Clin Biochem 1999; 36: 423-32.
20. Kinoshita S, Iida H, Inoue S, Watanabe K, Kurihara M, Wada Y, Tsuda H, Kang D, Hamasaki N. Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem 2005; 38: 908-15.
21. Miyata T, Hamasaki N, Wada H, Kojima T. More on: racial differences in venous thromboembolism. J Thromb Haemost 2012; 10: 319-20.
22. Chumpia W, Peerapittayamongkol C, Angchaisuksiri P, Komanasin N, Muta K, Kuaha K, Iida H, Inoue S, Wada Y, Kurihara M, Hamasaki N, Fucharoen S. Single nucleotide polymorphisms and haplotypes of protein C and protein S genes in the Thai population. Blood Coagul Fibrinolysis 2006; 17: 13-18.
23. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-73.
24. Meltzer ME, Bol L, Rosendaal FR, Lisman T, Cannegieter SC. Hypofibrinolysis as a risk factor for recurrent venous thrombosis; results of the LETS follow-up study. J Thromb Haemost 2010; 8: 605-7.
25. Heit JA, Cunningham JM, Petterson TM, Armasu SM, Rider DN, De Andrade M. Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism. J Thromb Haemost 2011; 9: 1133-42.
26. Reitsma PH, Versteeg HH, Middeldorp S. Mechanistic view of risk factors for venous thromboembolism. Arterioscler Thromb Vasc Biol 2012; 32: 563-8.
27. Tang L, Guo T, Yang R, Mei H, Wang H, Lu X, Yu J, Wang Q, Hu Y. Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population. PLoS One 2012; 7: e35773.
28. The Vascular Surgery Group of the Chinese Medical Association. The guidelines for diagnosis and treatment of venous thrombosis [in Chinese]. Chin J Gen Surg 2008; 23: 235-8.
29. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15: 7-12.
30. Taschner PE, den Dunnen JT. Describing structural changes by extending HGVS sequence variation nomenclature. Hum Mutat 2011; 32: 507-11.
31. Friedrich U, Blom AM, Dahlback B, Villoutreix BO. Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C. J Biol Chem 2001; 276: 24122-8.
32. Sun YH, Shen L, Dahlback B. Gla domain-mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding. Blood 2003; 101: 2277-84.
33. +)-induced phospholipid binding and severe functional protein S deficiency. Blood 2002; 100: 2812-19.
34. Okada H, Yamazaki T, Takagi A, Murate T, Yamamoto K, Takamatsu J, Matsushita T, Naoe T, Kunishima S, Hamaguchi M, Saito H, Kojima T. In vitro characterization of missense mutations associated with quantitative protein S deficiency. J Thromb Haemost 2006; 4: 2003-9.
35. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials 1990; 11: 116-28.
36. Dahlback B, Villoutreix BO. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol 2005; 25: 1311-20.
37. Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559-62.
38. Gandrille S, Aiach M. Identification of mutations in 90 of 121 consecutive symptomatic French patients with a type I protein C deficiency. The French INSERM network on molecular abnormalities responsible for protein C and protein S deficiencies. Blood 1995; 86: 2598-605.
39. Mahmoodi BK, Brouwer JL, ten Kate MK, Lijfering WM, Veeger NJ, Mulder AB, Kluin-Nelemans HC, van der Meer J. A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. J Thromb Haemost 2010; 8: 1193-200.
40. Miyata T, Sakata T, Yasumuro Y, Okamura T, Katsumi A, Saito H, Abe T, Shirahata A, Sakai M, Kato H. Genetic analysis of protein C deficiency in nineteen Japanese families: five recurrent defects can explain half of the deficiencies. Thromb Res 1998; 92: 181-7.
41. Dahlback B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 2008; 112: 19-27.
42. Khor B, van Cott EM. Laboratory tests for protein C deficiency. Am J Hematol 2010; 85: 440-2.
43. Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1988; 53: 505-18.
44. Friedrich U, Nicolaes GA, Villoutreix BO, Dahlback B. Secondary substrate-binding exosite in the serine protease domain of activated protein C important for cleavage at Arg-506 but not at Arg-306 in factor Va. J Biol Chem 2001; 276: 23105-8.
45. Gale AJ, Tsavaler A, Griffin JH. Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C. J Biol Chem 2002; 277: 28836-40.
46. Griffin JH, Fernandez JA, Gale AJ, Mosnier LO. Activated protein C. J Thromb Haemost 2007; 5(Suppl. 1): 73-80.
47. Gandrille S, Alhenc-Gelas M, Gaussem P, Aillaud MF, Dupuy E, Juhan-Vague I, Aiach M. Five novel mutations located in exons III and IX of the protein C gene in patients presenting with defective protein C anticoagulant activity. Blood 1993; 82: 159-68.
48. Faioni EM, Hermida J, Rovida E, Razzari C, Asti D, Zeinali S, Mannucci PM. Type II protein C deficiency: identification and molecular modelling of two natural mutants with low anticoagulant and normal amidolytic activity. Br J Haematol 2000; 108: 265-71.
49. Pomp ER, Doggen CJ, Vos HL, Reitsma PH, Rosendaal FR. Polymorphisms in the protein C gene as risk factor for venous thrombosis. Thromb Haemost 2009; 101: 62-7.